We showed previously that testosterone (T) alone could induce spermatogenesis and produce normally fertile spermatozoa in the absence of circulating gonadotropins. These studies used the hpg mouse, which is characterized by a congenital gonadotrophin deficiency due to a major deletion in the GnRH gene. Administering T by a subdermal implant of a SILASTIC brand tube impregnated with crystalline T showed that the androgenic requirement for full induction of spermatogenesis was a 1-cm length implant. Using this unique model of spermatogenesis without gonadotropins, we have now investigated the quantitative requirement for androgens to maintain spermatogenesis by testing the hypothesis that the androgenic threshold required for induction and maintenance of spermatogenesis are the same. Spermatogenesis was induced in homozygous hpg mice by T administration for 6 weeks. The first experiment determined the time-course of the regression of spermatogenesis after removal of the T-impregnated SILASTIC brand implant. Elongated spermatids were absent by 3 weeks and testicular weight regression was maximal by 4 weeks after androgen withdrawal. The second experiment examined the effects on maintenance of spermatogenesis of reducing the T dose. After full induction of spermatogenesis in homozygous hpg mice, the T implants were replaced with a range of smaller size T-impregnated SILASTIC brand implants for a further 4 weeks. All androgen-sensitive end-points (testis weight, tubular, and luminal diameters, round spermatids) were fully maintained with T implants of 0.06 cm and elongated spermatids with T implants of 0.25 cm. A further experiment showed that at very low T doses (0.06, 0.125 cm) the T effects observed at 4 weeks were maintained at 6 and 11 weeks duration. We conclude that the androgenic threshold to maintain spermatogenesis in the mouse is an order of magnitude lower than the threshold required for inducing spermatogenesis. This distinction suggests that the mechanism of action of testosterone in inducing spermatogenesis may involve regulation of a genetic switch to complete meiosis, whereas the maintenance involves a different locus of action. These findings suggest that further studies of androgen-dependent meiotic genes may be central to understanding the regulation and molecular basis of androgen-driven induction and maintenance of spermatogenesis. (Endocrinology 140: 3938 -3946, 1999) 
the effects on maintenance of spermatogenesis of reducing the T dose. After full induction of spermatogenesis in homozygous hpg mice, the T implants were replaced with a range of smaller size T-impregnated SILASTIC brand implants for a further 4 weeks. All androgen-sensitive end-points (testis weight, tubular, and luminal diameters, round spermatids) were fully maintained with T implants of 0.06 cm and elongated spermatids with T implants of 0.25 cm. A further experiment showed that at very low T doses (0.06, 0.125 cm) the T effects observed at 4 weeks were maintained at 6 and 11 weeks duration. We conclude that the androgenic threshold to maintain spermatogenesis in the mouse is an order of magnitude lower than the threshold required for inducing spermatogenesis. This distinction suggests that the mechanism of action of testosterone in inducing spermatogenesis may involve regulation of a genetic switch to complete meiosis, whereas the maintenance involves a different locus of action. These findings suggest that further studies of androgen-dependent meiotic genes may be central to understanding the regulation and molecular basis of androgen-driven induction and maintenance of spermatogenesis. (Endocrinology 140: 3938 -3946, 1999) M AMMALIAN spermatogenesis is tightly regulated by the pituitary gonadotropic hormones, LH and FSH, through their effects on the testis (1, 2) . The effects of LH are mediated via stimulation of Leydig cell testosterone synthesis, whereas FSH action is mediated via specific receptors located exclusively on Sertoli cells. Both testosterone and FSH act on spermatogenesis via their Sertoli cell receptors (3, 4) , but the individual role of each hormone and the nature of their interaction have not been fully defined. To analyze the hormonal regulation of spermatogenesis, it is necessary to abolish pituitary gonadotropin effects on the testis before examining the effects of each hormone alone and in combination. Classical models to abolish gonadotropin action such as hypophysectomy, steroidal negative feedback, GnRH receptor antagonists, and immunoneutralization all fall short of the ideal of specific, durable, and complete gonadotropin deficiency. We have been studying the hpg mouse as a valuable, naturally occurring genetic knock-out of the GnRH gene that produces specific, congenital, and complete gonadotropin deficiency. Identified originally as a spontaneous, autosomal recessive mutation causing a sterile mouse with infantile gonads (5) , the mutation has been characterized as a major deletion removing 2 of 4 exons in the murine GnRH gene (6) . The resulting permanent functional GnRH deficiency leads to undetectable circulating gonadotropin concentrations (5, 7) and infantile testes. The immature reproductive tract of hpg mice is, however, functionally competent as fertility and androgenic function can be restored when GnRH secretion is reinstated by genetic transfer of the GnRH gene (8) , by intracerebral transplantation of fetal GnRH neurons (9, 10) or GnRH-secreting immortalized tumor cells (11) as well as by frequent injections of GnRH (7) .
Exploiting this naturally occurring genetic inactivation of the GnRH gene, we previously showed that androgens alone, acting through the androgen receptor and without need for aromatization, can initiate qualitatively complete spermatogenesis in the presence of low intratesticular testosterone and undetectable circulating FSH (12) . In this model of complete functional FSH deficiency, the spermatozoa produced have quantitatively normal fertilizing ability in vitro (12) and in vivo (Allan, C. M., and D. J. Handelsman, unpublished data). The appearance of round and elongated spermatids in hpg mouse testis induced by androgen treatment-when these cells are completely lacking before treatment-demonstrates that T, without FSH, is required physiologically for the completion of meiosis (round spermatids) and spermiogenesis (elongated spermatids). The rate-limiting step appears to be the completion of meiosis that is remarkably sensitive to T. Although androgens (T or DHT) produced a striking growth response in hpg testes, maximal testis size was 30 -50% of non-hpg control. This was attributable to the number of Sertoli cells being also 30 -50% of non-hpg controls, whereas the number of germ cells per Sertoli cell was quantitatively normal (12) . These findings were confirmed in mice with inactivated genes for the FSH ␤-subunit (13) or the FSH receptor (14) , but where endogenous LH and testosterone secretion were unimpaired. In both models, the same reproductive phenotype as observed in T-treated hpg micesmall testis (ϳ30 -50% normal) of normal morphology and producing fertile spermatozoa-was observed. These findings are consistent with the concept that mature testis size is largely determined by extent of Sertoli cell proliferation during late prenatal and early postnatal life before germ cell replication occurs. The stock of Sertoli cells thereby determines final testis size because each Sertoli cell has a fixed, finite capacity for numbers of germinal cells that it can support. This mechanism is supported by the fact that neonatal FSH treatment increases Sertoli cell number (and thereby final germ cell capacity and mature testis size) (15) , whereas even intensive FSH treatment after the age when Sertoli cell replication usually ceases is ineffective (16) . Similar modifications of mature testis size by manipulation of the postnatal stock of Sertoli cells have been achieved by neonatal hemicastration (17) , hypothyroidism (18) , or FSH treatment (19) .
Given that we had clearly established the T dosage threshold and locus of action involved in induction of spermatogenesis, the question arose whether the hormonal-dependent mechanism that maintains spermatogenesis is the same as that required to initiate it. To characterize these mechanisms, the present study aimed to determine whether the androgenic threshold required to maintain spermatogenesis was the same as the well characterized threshold required to induce it.
Materials and Methods Animals
The University of Sydney hpg mouse colony originating from stock (C3H/HeH X 101/H) kindly provided by Dr. H. Charlton (University of Oxford) has been described previously (12) . Mice are housed under standard controlled environmental conditions (lights on 0700 -1900; temperature 20 -24 C) in groups of 3-4 per cage with free access to mouse cubes and water. All operative procedures are performed under anesthesia administered by ip injection (0.01 ml/g body weight) of a 0.5% solution of ketamine (Parke-Davis, Caringbah, New South Wales, Australia) and xylazine (Bayer Australia Ltd, Botany, New South Wales, Australia). Mice are killed by anesthetic overdose. All procedures were approved by the Animal Ethics Committee of the University of Sydney within national guidelines for animal experimentation. All chemicals are of analytical grade and obtained from Sigma Chemical Co. unless otherwise specified.
Genotyping
Mice were genotyped by a duplex PCR on proteinase-K digests of tail snips as described previously (12) and modified from the original method (20) . The PCR products were separated on agarose gel to distinguish three genotypes (N/N, N/hpg and hpg/hpg) deduced from the presence and size of one or two expected bands.
SILASTIC implants
SILASTIC brand implants filled with crystalline T (Sigma Chemical Co.) were prepared from SILASTIC brand tubing (id 1.47 mm,od 1.95 mm; Dow Corning Corp., Midland, MI, catalog no. 602-235) and sealed at both ends with SILASTIC brand adhesive (Dow Corning Corp. 734RTV). Given the fixed thickness of the tubing and the diffusion rate of testosterone through SILASTIC, the length of SILASTIC brand tubing determines testosterone release rate. The implant length refers to the length of SILASTIC brand tubing filled with crystalline steroid exposed to the extracellular fluid and therefore available for steroidal release. The shortest tubing length that could be manufactured satisfactorily was 0.06 cm. Subdermal SILASTIC brand T implants provide accurate and predictable blood and intratesticular concentrations as described previously (12) .
Experimental design
Regression of spermatogenesis (Exp 1). To estimate the testosterone requirement for maintenance of spermatogenesis, it was necessary first to establish the time-course of spermatogenic regression after removal of T-filled implants. The duration of the experiment was based on the duration of the spermatogenic cycle (35 days) in the mouse (21) . Weanling (day 21) hpg mice had spermatogenesis induced by subdermal implantation of a 1 cm T-filled SILASTIC brand tubing under anesthesia (n ϭ 6 -8 per group) for 6 weeks as described previously (12) . Following this induction of spermatogenesis, the 1 cm T implant was removed from all mice. The rate and extent of spermatogenic regression was determined by estimating testis weight and elongated spermatid counts at 0, 1, 2, 3, 4, and 6 weeks after implant removal. The experiments ended with the mice being killed by anesthetic overdose and testes rapidly excised. The right testis was weighed and used for quantitation of elongated spermatids by the homogenization method (22) .
Maintenance of spermatogenesis (Exp 2)
To determine the androgenic threshold for maintenance of spermatogenesis, full spermatogenesis was first induced in weanling hpg mice by subdermal implantation of a 1 cm T-filled SILASTIC brand tubing for 6 weeks. At 9 weeks of age, mice (n ϭ 8 -19 per group) were then randomly allocated to subsequent treatments consisting of replacement of the original 1 cm implant with T-filled SILASTIC brand implants of various lengths (0, 0.06, 0.20, 0.25, 0.5, 1 cm) for a further 4 weeks. At the end of this experiment, all mice were killed to harvest testes for measurement of testis weight, for enumeration of elongated spermatids by homogenization (n ϭ 8 -19 per group) and for stereological measurements (n ϭ 2-4 per group).
Long-term maintenance of spermatogenesis by low-dose T (Exp 3)
To determine if low T doses could maintain spermatogenesis over a longer period, the design of Exp 2 was repeated with induction of full spermatogenesis by subdermal implantation of a 1 cm T-filled SILASTIC brand tubing into weanling hpg mice for 6 weeks. At 9 weeks of age, mice (n ϭ 4 -8 per group) had the original 1 cm implant removed and were then switched to a maintenance implant of either 0.0625 or 0.125 cm for a further 6 or 11 weeks. For the 11 week group, the implant was changed after 6 weeks to maintain steady T delivery. At the end of Exp 3, mice were killed to harvest testes for measurement of testis weight, for enumeration of elongated spermatids by homogenization (n ϭ 4 -8 per group) and for stereological measurements (n ϭ 2-5 per group).
Testicular histology
In each experimental group, 2-5 mice underwent vascular perfusion fixation by whole body perfusion while anesthetized. Briefly, 30 ml warm physiological saline containing 10 IU/ml heparin (Monoparin, Australia) was perfused through the left ventricle, while the vena cava was incised to allow efflux of perfusate. This was followed by 30 ml of fixative consisting of 2% glutaraldehyde, 2% paraformaldehyde and 0.1% picric acid buffered in 0.2 m sodium phosphate (pH 7.4). After fixation, well-perfused testes were cut into blocks that were immersed overnight in fixative and then dehydrated in graded concentrations of ethanol and embedded in Spurr's resin oriented to ensure maximal perpendicular orientation of seminiferous tubules to the cut edge. Semithin (1 micron) sections were cut by an ultramicrotome (Reichert-Jung, Austria) and stained with 1% toluidine blue.
Stereological estimation
Germ cells were classified into spermatogonia, primary spermatocytes and round spermatids according to Russell (23) . Corrections were made for shrinkage of tissue during processing as described previously (12) . The numerical density (Nv) of germ cells (spermatogonia, primary spermatocytes and round spermatids) and Sertoli cells within the testis was determined from areal density of nuclei using a Carl Zeiss image analysis system (Kontron KS400). Nuclear profiles in cross sectional view from random tubules were traced using a 40ϫ objective to provide mean area and mean intercept length/chord length for each nucleus. The number of each germ cell type was quantitated as described previously (12) according to the de Hoff and Rhines equation (24), with the assumption that each cell has a single nucleus. The numerical density was then multiplied by the volume of the testis (determined from testicular weight and specific gravity, V ϭ Testis weight/specific gravity) to give absolute number of each germ cell type per testis. The number of Sertoli cell nuclei per testis was determined as described previously (12) according to the equation of Zhengwi (25) and established methods (26) . The volume density of tubules in the testis was derived from tubular area obtained by tracing tubular perimeter from cross-sectional views using 10ϫ objective. Tubular and luminal diameters were also determined from perimeter measurements.
Testicular homogenization
Individual testes were weighed, decapsulated and the parenchyma homogenized (Potter S, Braun, Germany) at maximum speed (1500 rpm) for 1 min in 1-2 ml of homogenizing fluid containing 150 mm sodium chloride, 0.1% (vol/vol) Triton X-100 (22) . Elongated spermatid nuclei resistant to homogenization (steps 14 -16) were counted in hemocytometer chambers. Counts for five chambers were averaged and the numbers of spermatids expressed per whole testis and per gram of testis.
Data analysis
Analysis of stereological data were carried out using JMP statistical software (SAS Institute, Inc., Cary, NC). Data were expressed as mean and sem. The presence of statistically significant differences among the various treatment groups was determined using one way ANOVA with suitable posthoc contrasts using SAS software. A P value of Ͻ0.05 was taken to indicate statistical significance and all references to no quantitative differences being evident imply a P value Ͼ0.05.
Results

Testis weight
Following full induction of spermatogenesis with a single 1 cm T implant for 6 weeks, the implant was removed. In the regression of spermatogenesis (Exp 1), testis weight declined progressively from a maximally stimulated weight of 27.8 Ϯ 1.9 mg to a minimal weight of 4.1 Ϯ 0.3 mg at 4 weeks post treatment (Fig. 1, upper panel) .
For Exp 2, examining maintenance of spermatogenesis, a duration of 4 weeks was selected. In this experiment, maximal testis weight induced by a single 1 cm implant was maintained for a further 4 weeks by replacement with a single 0.06 cm T implant (Fig. 1, lower panel) . This T dose was as effective as a single 1 cm T implant in maintaining testis weight at 4 weeks (24.2 Ϯ 1.8 vs. 27.2 Ϯ 1.8 mg, P Ͼ 0.05). Testis weight was also not significantly different (P Ͼ 0.05) at 6 (29.5 Ϯ 2.5 mg) and 11 (24.2 Ϯ 5.4 mg) weeks indicating sustained maintenance by a T dose of 0.06 cm for up to 11 weeks. For comparison, testis weight in mature non-hpg mice of the same strain is 96.1 Ϯ 2.4 mg (12).
Testicular histology
Four weeks after removal of the T implant that induced full spermatogenesis, the histological appearance of the testis of the androgen withdrawn hpg testis was essentially similar to the untreated hpg (not shown). Germ cells up to the pachytene spermatocyte stage were observed but there were no elongated or round spermatids present in the germinal epithelium. The tubules showed a marked reduction in diameter and the tubular lumen was absent in all tubules observed. The stratification of the epithelium appeared distorted in some tubules with Sertoli cell nuclei positioned randomly within the epithelium (Fig. 2a) .
Replacement of the 1 cm with a 0.06 cm T implant maintained all stages of spermatogenesis. In particular, round and , Time course of regression of spermatogenesis after withdrawal of testosterone by removal of testosterone filled SILASTIC brand subdermal implants. Spermatogenesis was induced in weanling homozygous hpg mice by implantation of a 1 cm subdermal testosterone for 6 weeks. Following removal of testosterone implants testis weight (circles) and homogenization-resistant, elongated spermatids (diamonds) were observed at various times up to 6 weeks after implant removal. Data plotted as mean and SEM. Asterisks indicates significant difference (P Ͻ 0.05) from 6 week value. Statistically, plateau of regression was achieved for testis weight at 4 weeks and for homogenization-resistant elongated spermatids at 3 weeks. Lower panel (Exp 2), Dose response relationship for maintenance of testis weight (circles) and elongated spermatids (diamonds) according to testosterone dose according to length of SILASTIC brand implant. Data plotted as mean and SEM. Asterix indicates significant difference (P Ͻ 0.05) from plateau level of maintenance. Statistically, plateau of maintenance of testis weight was achieved at a testosterone dose of 0.06 cm and for homogenization-resistant elongated spermatids at a testosterone dose of 0.25 cm.
fully differentiated sperm were present in the epithelium (Fig. 2, c and d ). Replacement with a 1 cm implant (Fig. 2b ) produced similar germ cell development with fully differentiated sperm present.
Stereology
Tubular and luminal diameters. In the maintenance experiment, tubular diameter (Fig. 3, lower panel) in the untreated (91 Ϯ 2 microns) was increased to 139 Ϯ 17 microns with 4 weeks of 1 cm T treatment. This increase reflected mainly the enlargement in lumen diameter (Fig. 3, upper panel) from 0 in untreated to 49 Ϯ 3 microns in the 1 cm group. At 4 weeks, even the lowest T dose (0.06 cm) maintained the tubular (160 Ϯ 0 microns) and luminal (42 Ϯ 6 microns) diameters at levels comparable with a single 1 cm T implant. The same low (0.06 cm) T dose maintained tubular and luminal diameters at 6 (159 Ϯ 13, 47 Ϯ 2 microns) and 11 (148 Ϯ 9, 54 Ϯ 6 microns) weeks, respectively (all P Ͼ 0.05). The tubular and luminal diameters were similarly maintained by the 0.125 cm T dose at 6 and 11 weeks (data not shown, P Ͼ 0.05). For comparison, the tubular and luminal diameters of non-hpg control mice of the same strain was 215 Ϯ 7 microns and 84 Ϯ 2 microns, respectively (12) .
Germ and Sertoli cell numbers
Round spermatids increased dramatically from zero in untreated mice to 7.30 Ϯ 0.55 million/testis in mice given a single 0.06 cm T implant (Fig. 4) . This was not significantly different from the numbers of round spermatids produced by the 1 cm implant (8.29 Ϯ 0.33 million/testis). Primary spermatocyte numbers were moderately increased by T (untreated 1.23 Ϯ 0.31 million/testis, lowest T dose 2.58 Ϯ 0.13 million/testis, highest T dose 3.47 Ϯ 0.33 million/testis). Spermatogonial numbers were not significantly increased by T (untreated 1.23 Ϯ 0.22 million/testis, lowest T dose 1.05 Ϯ 0.05 million/testis, highest T dose 1.43 Ϯ 0.15 million/testis). The numbers of Sertoli cells (Fig. 4, inset) was unchanged by T treatment (untreated 0.69 Ϯ 0.06 million/testis, lowest dose 0.77 Ϯ 0.12 million/testis, highest dose 0.86 Ϯ 0.04 million/ testis). The germ cell populations were fully maintained by the lowest T dose (0.06 cm) at 6 and 11 weeks ( 
Germ and Sertoli cell ratios
The numerical density of germ cells was also analyzed according to the ratio of each germ cell population per Sertoli cell (Fig. 6, upper panel) . The ratio of round spermatids to Sertoli cells is maintained by the lowest T dose (8.73 Ϯ 1.91) at levels similar to the highest T dose (10.33 Ϯ 1.01). No T dose had any significant effect on the ratio of spermatogonia to Sertoli cells whereas the lowest T dose produced an increase in the ratio of spermatocytes to Sertoli cells (3.1 Ϯ 0.49 vs. 1.74 ϩ 0.28 in untreated) but this was no different from the effects of the highest T dose (4.01 Ϯ 0.26). Similar findings were observed for both lower T doses (0.06, 0.125 cm) at 6 and 11 weeks (data not shown, P Ͼ 0.05). For comparison with non-hpg mice of the same strain, the numbers of spermatogonia, spermatocytes, round spermatids and Sertoli cells were 0.59 Ϯ 0.15, 2.38 Ϯ 0.25, 6.48 Ϯ 0.70, and 2.66 Ϯ 0.16 million per testis, respectively (12) .
The effects of T on the progression ratios of germ cells was also analyzed (Fig. 6, lower panel) . T dramatically increased the ratio of round spermatids to primary spermatocytes reflecting T-stimulated induction of round spermatid production (0 in untreated vs. 2.82 Ϯ 0.07 at lowest T dose) and this ratio was no further increased at the highest T dose (2.62 Ϯ 0.48). Similar effects were also observed in the ratio of spermatocytes to spermatogonia, whereby the lowest T dose produced maximal increase in the ratio. Both lower T doses (0.06, 0.125 cm) maintained the same ratios at 6 and 11 weeks (data not shown, P Ͼ 0.05).
Testicular elongated spermatid counts
The number of homogenization-resistant elongated spermatids at the end of 6 weeks induction of spermatogenesis by a 1 cm T implant was 0.90 ϩ0.04 million/testis. This declined sharply to 0.14 Ϯ 0.03 million/testis at 2 weeks after T implant removal and at 3 weeks spermatids were totally absent (Fig. 1a) .
The lowest T dose (0.06 cm) produced a significant increase in homogenization-resistant elongated spermatid numbers (0.47 Ϯ 0.09 million/testis) but a 0.25 cm T implant was required for a maximal induction of homogenizationresistant elongated spermatids number (1.73 Ϯ 0.31 million/ testis) (Fig. 1b) . The number of homogenization-resistant elongated spermatids maintained by the 0.06 cm dose at 6 (0.39 Ϯ 0.08 million/testis) and 11 (0.36 Ϯ 0.07 million/testis) weeks as well as the numbers maintained by the 0.125 cm dose at 6 (0.38 Ϯ 0.08 million/testis) and 11 (0.34 Ϯ 0.05 million/testis) weeks were all closely comparable but had a nonsignificant trend (P Ͼ 0.05) to be maintained at lower numbers compared with 4 weeks (0.47 Ϯ 0.09 million/testis). For comparison with non-hpg mice of the same strain, the numbers of homogenization-resistant elongated spermatids was 13.3 Ϯ 0.7 million/testis (12) . When the numbers of homogenization-resistant spermatids were alternatively expressed as million per mg testis, a similar dose-response to T was observed (data not shown) and values were not significantly different from non-hpg mice of the same strain (0.11 Ϯ 0.1 million/mg testis weight) (12) .
Discussion
The present study shows that maintenance of spermatogenesis requires a 16-fold lower (0.06 vs. 1 cm) androgenic threshold compared with induction of spermatogenesis (12) . This was evident consistently for testis weight, tubular and luminal diameters as well as round spermatid numbers. The mean circulating T concentration represented by the lowest T dose in these studies is well within physiological levels for mature male mice (12) . This remarkable efficacy is most probably attributable to the steady-state mode of hormone delivery via SILASTIC brand implants that achieves greater androgenic potency than intermittent secretion or injections (27) . The present studies were unable to determine the minimum T dose required for full maintenance as the lowest T dose was still maximally effective for most variables yet it was technically not feasible to make SILASTIC brand implants of smaller size. Therefore the actual minimum threshold T dose (or circulating levels) for the maintenance of spermatogenesis remains to be determined. This study, however, reinforces our previous observation that the most T sensitive step is the completion of meiosis (12), a finding that was inferred from much earlier studies (1) . This observation indicates the need for caution in interpreting studies of androgen effects on germ cell populations and kinetics that are based on creating gonadotropin deficiency by using T negative feedback as administration of even apparently low T doses may systematically alter the observed patterns leading to misinterpretations (28 -31) such as that completion of spermiogenesis is the major androgen dependent step (31, 32) .
In this study, the elongated spermatid population required a somewhat higher T dose (0.25 cm) for full maintenance at 4 weeks, and there was a tendency for lower T doses to be unable to fully sustain the elongated spermatid numbers at longer durations. This high T threshold was still 4-fold lower than required for induction of spermatogenesis. This is consistent with our previous quantitative studies in that the lowest T dose produced 79% of maximal round spermatids but only 17% of maximal elongated spermatids (12) . In addition, this is consistent with other evidence that spermiogenic differentiation (round to elongated spermatids) in the rat may have a higher T threshold (32, 33) . It is also possible, however, that this apparently higher threshold may be artificially elevated if at lower T doses the elongated spermatid nuclei are less well condensed and being more fragile are less resistant to homogenization. If so, this would result in artefactually lowered estimates of elongated spermatid numbers but direct evidence for this interpretation is lacking. It also cannot be excluded that FSH may influence the quantitative requirement for maintenance of late stage elongated spermatids (34) . In this context, it is conceivable that the evidence suggesting that FSH may be an important regulator of meiosis (33) and of testicular seasonality in the hamster (35) , may reflect a mechanism whereby FSH increases Sertoli cell sensitivity to testosterone.
This study supports numerous previous observations that T is necessary to maintain mammalian spermatogenesis (2) , although the precise dose requirement and mechanism of action remain unclear. Beyond the absolute need for T, this study demonstrates for the first time that, in the absence of Asterisks indicates significant differences (P Ͻ 0.05) from zero testosterone dose. Round spermatid numbers were maximally stimulated by the lowest testosterone dose (0.06 cm) with no significant change between higher testosterone doses. Spermatocytes were significantly increased at only the highest three doses (Ն0.25 cm). There was no significant dose-dependent change in spermatogonial or Sertoli cell numbers. FSH, the threshold dose of T required to maintain complete spermatogenesis is much lower than that required to induce it. While many studies have investigated the effect of T on the initiation or reinitiation of spermatogenesis after regression, fewer studies have examined the quantitative requirement for testosterone in maintenance of mammalian spermatogenesis. There appear to be no previous studies examining the hormonal requirements for maintenance of spermatogenesis in the mouse. Previous studies of the maintenance of rat spermatogenesis from a variety of models of gonadotropin deficiency have suggested the androgenic threshold to maintain quantitatively normal spermatogenesis is relatively high. The reason for these discrepancies between studies mainly conducted in the rat and our present findings in the mouse may be more than simply species variation. For such a evolutionarily vital mechanism such as reproduction, major variations in regulation seem inherently unlikely. Other possible reasons for these discrepancies may be differences between the models. For example, none of the other models apart from hypophysectomy eliminate FSH consistently, whereas hypophysectomy removes all other pituitary hormones and many pituitary-dependent growth factors. In particular, administration of T leads to increases in circulating FSH where a state of transient gonadotrophin deficiency has been created in rats with previously normal FSH secretion by GnRH immunization (36) or GnRH analogs (37, 38) . Similarly the use of T plus estradiol in SILASTIC brand implants to create gonadotropin deficiency effectively eliminates LH but not FSH secretion (28 -31) .
Following the induction of spermatogenesis in the hpg mouse, the removal of T leads to complete loss in the haploid germ cell populations but the premeiotic cells are either little (spermatocytes) or not (spermatogonia) affected. Consistent findings are observed in tfm mice which, despite a complete lack of functioning androgen receptors, maintain early spermatogenesis arrested at the first meiotic division (3) indicating that the early premeiotic stages of spermatogenesis are androgen independent. Because T alone is necessary and sufficient to induce and maintain the haploid germ cell population, we infer there must be an important effect on pachytene spermatocytes that switches on progression to complete meiosis.
The present study confirms that testosterone is not only absolutely required for meiosis and for efficient spermiogenesis, but that once spermatogenesis has been initiated, the T requirement to sustain meiosis is reduced substantially. These differing thresholds for T effects suggests that the mechanism of action of T may be different for induction and maintenance of spermatogenesis. Sertoli cell plays a central role in the structural support and compartmentalization of the germinal epithelium to provide a unique nutritional environment for developing germinal cells (39) . Androgen receptors are located on the Sertoli cell (40) where their expression is critical for spermatogenesis, whereas germ cell expression is not (3) . Hence the effect of T on completion of meiosis and spermiogenesis are most likely mediated via Sertoli cells despite demonstration of androgen receptors on step XI elongated spermatids (41) . A single 0.06 cm T implant can fully maintain differentiated Sertoli cell histology, whereas in our previous initiation study a 1 cm T implant was required for these maturational changes to occur. In contrast, the maintenance of spermatogonia and spermatocytes appears to be independent of T. This suggests that T-dependent Sertoli cell activity must be closely linked to meiotic and post meiotic events in the germinal epithelium. The spermiogenic effects of T could involve enhanced binding by spermatids to Sertoli cells, which prevents their premature detachment from the epithelium (42, 43) . Androgen binding protein (ABP) secretion may also be important for the maintenance of step 18 -19 spermatids, indicating an indirect mechanism of T on germ cells via Sertoli cell transport of the hormone across the tight junction barrier while bound to ABP (34) . The reduced requirement for T during maintenance of spermatogenesis may reflect the requirement of a fully differentiated and functional Sertoli cell in contrast to that of a immature Sertoli cell, which matures during initiation. It is well established that the Sertoli cell undergoes many morphological and functional changes during the initiation of spermatogenesis. For example, cell shape changes to tall columnar with the nucleus becoming irregular and migrating to a basal position in the epithelium (44) . Fluid secretion by the Sertoli cell (45) also commences into the tubular lumen and is regulated primarily by androgens (46 - Asterisks indicate significant differences from zero testosterone dose. All testosterone doses (Ն0.06 cm) significantly increased (P Ͻ 0.05) round spermatid to Sertoli cell, spermatocyte to Sertoli cell, round spermatid to spermatocyte and spermatocyte to spermatogonial ratios compared with zero testosterone dose. There was no significant dose-dependent change in spermatogonia to Sertoli cell ratio. 48), whereas FSH has negligible effects (49) . In the present study, in the absence of T, tubular lumen diameter decreased and haploid cells are lost but both were maintained with T treatment. This indicates a close functional linkage between T-dependent Sertoli cell secretory activity and the requirements of spermatid maturation and release (50) . The molecular basis for this heightened androgen sensitivity is unknown but would be consistent with a increased expression of androgen receptors or their coactivators.
We conclude that the androgenic threshold requirement for maintenance of spermatogenesis in the mouse is much lower than the threshold for full induction of spermatogenesis. This androgenic effect is manifest most directly in the completion of meiosis with secondary and less sensitive effects on the completion of spermiogenesis. The very low androgenic requirement to maintain spermatogenesis has important implications for understanding the hormonal regulation of spermatogenesis.
